AMedicina - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 7,512 | 21,538 | 36,423 | 39,451 | 11,247 | 14,208 | 30,102 | 79,253 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | 114 | 94 | 874 | 4,334 | -9,120 | 30,740 | -11,892 | 212 |
| Equity | -34,742 | -34,648 | -33,774 | -29,440 | -38,560 | -7,820 | -19,712 | -19,500 |
| Liabilities | 37,221 | 41,027 | 50,179 | 42,001 | 44,905 | 11,510 | 39,658 | 38,616 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,100 |
| Current assets | 2,479 | 6,379 | 16,405 | 12,561 | 6,345 | 3,690 | 19,946 | 18,016 |
| Total assets | 2,479 | 6,379 | 16,405 | 12,561 | 6,345 | 3,690 | 19,946 | 19,116 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 604 | 3,798 | 25,381 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -81.3% | +186.7% | +69.1% | +8.3% | -71.5% | +26.3% | +111.9% | +163.3% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 4.6% | 1.5% | 5.3% | 34.5% | -143.7% | 833.1% | -59.6% | 1.1% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 1.5% | 0.4% | 2.4% | 11.0% | -81.1% | 216.4% | -39.5% | 0.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 7,512 | 21,538 | 36,423 | 31,561 | 5,624 | 10,029 | 30,102 | 79,253 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
AMedicina - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 1.20 |
| 2026-08-26 | 2026-09-02 | 1.20 |
| 2026-08-23 | 2026-08-23 | 1.20 |
| 2026-08-19 | 2026-08-19 | 1.20 |
| 2026-08-16 | 2026-08-16 | 1.20 |
| 2026-07-27 | 2026-08-14 | 1.20 |
| 2026-07-26 | 2026-07-26 | 0.06 |
| 2026-07-23 | 2026-07-25 | 1.20 |
| 2026-07-19 | 2026-07-22 | 0.06 |
| 2026-07-16 | 2026-07-17 | 0.06 |
| 2026-06-16 | 2026-07-14 | 0.06 |
| 2026-06-11 | 2026-06-14 | 0.06 |
| 2026-05-19 | 2026-06-08 | 0.06 |
| 2026-05-17 | 2026-05-18 | 1054.84 |
| 2026-05-03 | 2026-05-14 | 0.06 |
| 2026-04-20 | 2026-04-29 | 0.06 |
| 2026-03-29 | 2026-04-14 | 0.06 |
| 2026-03-17 | 2026-03-27 | 0.06 |
| 2026-03-15 | 2026-03-15 | 0.06 |
| 2026-02-18 | 2026-03-11 | 0.06 |
| 2026-01-16 | 2026-02-16 | 0.06 |
| 2026-01-01 | 2026-01-14 | 0.06 |
| 2025-12-16 | 2025-12-30 | 0.06 |
| 2025-11-18 | 2025-12-14 | 0.06 |
| 2025-10-16 | 2025-11-16 | 0.06 |
| 2025-09-16 | 2025-10-14 | 0.06 |
| 2025-09-07 | 2025-09-14 | 0.06 |
| 2025-08-31 | 2025-09-03 | 0.06 |
| 2025-08-19 | 2025-08-29 | 0.06 |
| 2025-07-16 | 2025-08-17 | 0.06 |
| 2025-06-17 | 2025-07-14 | 0.06 |
| 2025-06-08 | 2025-06-09 | 0.06 |
| 2025-05-16 | 2025-06-04 | 0.06 |
| 2025-05-04 | 2025-05-12 | 0.06 |
| 2025-04-16 | 2025-04-30 | 0.06 |
| 2025-03-18 | 2025-04-14 | 1.12 |
| 2025-02-18 | 2025-03-13 | 1.12 |
| 2025-01-16 | 2025-02-16 | 1.12 |
| 2025-01-02 | 2025-01-14 | 1.12 |
| 2024-12-22 | 2024-12-31 | 1.12 |
| 2024-12-17 | 2024-12-20 | 1.12 |
| 2024-11-18 | 2024-12-15 | 1.12 |
| 2024-10-24 | 2024-11-14 | 1.12 |
| 2024-10-16 | 2024-10-23 | 1.09 |
| 2024-09-17 | 2024-10-06 | 1.09 |
| 2024-08-19 | 2024-09-09 | 1.09 |
| 2024-07-24 | 2024-08-18 | 0.03 |
| 2024-07-16 | 2024-07-16 | 25.73 |
| 2024-06-18 | 2024-07-15 | 1.06 |
| 2024-05-17 | 2024-06-16 | 1.06 |
| 2024-05-16 | 2024-05-16 | 25.73 |
| 2024-04-23 | 2024-05-15 | 1.06 |
| 2024-04-17 | 2024-04-22 | 0.62 |
| 2024-04-16 | 2024-04-16 | 49.96 |
| 2024-03-18 | 2024-04-15 | 25.29 |
| 2024-02-19 | 2024-03-17 | 0.62 |
| 2024-01-23 | 2024-02-14 | 22.95 |
| 2024-01-16 | 2024-01-22 | 22.33 |
| 2023-12-18 | 2024-01-11 | 44.63 |
| 2023-11-16 | 2023-12-17 | 22.30 |
| 2023-09-18 | 2023-10-11 | 22.15 |
| 2023-06-16 | 2023-07-09 | 25.08 |
| 2023-02-17 | 2023-03-15 | 0.26 |
| 2023-01-17 | 2023-01-18 | 84.48 |
| 2022-11-21 | 2022-11-21 | 54.92 |
| 2022-11-17 | 2022-11-18 | 54.92 |
| 2022-07-18 | 2022-07-20 | 84.30 |
| 2022-01-18 | 2022-01-18 | 81.02 |
| 2021-09-16 | 2021-09-26 | 19.65 |
AMedicina - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company AMedicina is: 113 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 112.86 |
| 2026-08-28 | 2026-08-31 | 112.68 |
| 2026-08-18 | 2026-08-25 | 112.68 |
| 2026-08-14 | 2026-08-17 | 113.34 |
| 2026-07-01 | 2026-08-13 | 112.68 |
| 2026-06-30 | 2026-06-30 | 94.43 |
| 2026-06-28 | 2026-06-29 | 6.0 |
| 2026-05-28 | 2026-06-05 | 6.0 |
| 2026-04-30 | 2026-05-25 | 6.0 |
| 2026-01-15 | 2026-01-15 | 16.22 |
| 2025-10-30 | 2025-11-27 | 5.71 |
| 2025-08-27 | 2025-09-25 | 3.71 |
| 2025-07-28 | 2025-08-26 | 6.71 |
| 2025-06-02 | 2025-06-10 | 90.23 |
| 2025-05-31 | 2025-06-01 | 78.14 |
| 2024-10-28 | 2024-11-25 | 2.0 |
| 2024-09-29 | 2024-10-16 | 2.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
AMedicina, UAB is a private limited liability company (code 300064899) operating in the wholesale of pharmaceutical and medical goods. In 2025, the company generated EUR 79.3K in revenue, up 163.3% year on year and 457.8% compared with 2023. The business moved from EUR 14.2K of revenue in 2023 to EUR 30.1K in 2024 and then to a much stronger sales base in 2025. Net profit followed a more volatile path: EUR 30.7K in 2023, a loss of EUR 11.9K in 2024, and a small profit of EUR 212 in 2025, leaving the latest profit margin at 0.3%. The balance sheet remained pressured, with total assets of EUR 19.1K, equity of minus EUR 19.5K and liabilities of EUR 38.6K at the end of 2025. Asset turnover was 4.15x, indicating relatively efficient use of the asset base to support revenue. Revenue per employee reached EUR 79.3K, while profit per employee was EUR 212, reflecting the company’s low absolute earnings in the latest year.